The invention provides methods for treating cancer/tumor growth by administering a DII4 antagonist, in particular, DII4 antibodies and fragments thereof that specifically bind human DII4, optionally with a VEGF antagonist and chemotherapeutic agents. Pharmaceutical compositions and kits containing DII4 antagonists, VEGF antagonists and chemotherapeutic agents are also provided.